Phase 2 Angina Pectoris Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 2
Assessing the Safety and Effectiveness of Intracoronary Stem Cells in Patients With Refractory Angina
Refractory AnginaRefractory Angina Pectoris
Barts & The London NHS Trust110 enrolled1 locationNCT05711849
Recruiting
Phase 2Phase 3
Efficacy of Targeted Medical Therapy in Angina and Nonobstructive Coronary Arteries
Angina PectorisMicrovascular AnginaVasospastic Angina+1 more
Stanford University150 enrolled1 locationNCT06424834
Terminated
Phase 2
A Phase II, Double Blind, Placebo-controlled, Randomized, Multi-Center, Parallel Group Study to Evaluate The Efficacy and Safety of T89, drug name: Dantonic 'Registered trade mark' in Patients with Chronic Stable Angina Pectoris
Chronic Stable Angina PectorisAngina
CNS Pty Ltd70 enrolled1 locationACTRN12609000044224